Accueil   Diary - News   All news ORPHELIA Pharma awarded a grant from the region Île-de-France to support business activity development in Europe and in the US

ORPHELIA Pharma awarded a grant from the region Île-de-France to support business activity development in Europe and in the US

 

 

Paris and Lyon, January 26th, 2021. ORPHELIA Pharma, a French biopharmaceutical company dedicated to the development and marketing of paediatric and orphan drugs announces today that it has received the support from the region Île-de-France as part of the PM’up program to accelerate the development of the company in Europe and the US. ORPHELIA Pharma will receive a grant of 250 000 € aimed at supporting the international development of the company.

 


We are grateful to receive the support from region Île-de-France which will allow us to accelerate the development of our medicines portfolio worldwide. Our products address unmet medical needs of life-threatening paediatric diseases and our ambition is to make them available to all patients“, comments Jeremy Bastid, Chief Development Officer of ORPHELIA Pharma.

 

 

Read the press release